Maxipime and Vancomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxipime (cefepime hydrochloride) and Vancomycin (vancomycin). Common drug interactions include perineal abscess among females and cytokine release syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Maxipime and Vancomycin. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Maxipime?

Maxipime has active ingredients of cefepime hydrochloride. eHealthMe is studying from 4,279 Maxipime users. Check the latest studies of Maxipime.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.



On Jul, 04, 2026

57 people who take Maxipime and Vancomycin together, and have interactions are studied.

Maxipime and Vancomycin drug interactions.

What are the common drug interactions of Maxipime and Vancomycin, by gender? *:

female:

  1. Perineal abscess
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Sudden death
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Urinary tract infection
  7. Vaginal cellulitis (vaginal spreading skin infection)
  8. Vulval abscess
  9. Vulval cellulitis (inflammation of skin around vagina)
  10. Abdominal pain upper

male:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Chronic kidney disease
  3. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  4. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Blood folate decreased
  8. Death
  9. Decreased activity
  10. Emotional distress

What are the common drug interactions of Maxipime and Vancomycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Drug ineffective
  4. Escherichia infection (bacterial infection by escherichia coli)
  5. Urinary tract infection bacterial

10-19:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Depressed level of consciousness
  3. Dyspnoea (difficult or laboured respiration)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  6. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Death
  5. Decreased activity
  6. Emotional distress
  7. Fear
  8. Impaired work ability
  9. Pain
  10. Quality of life decreased

30-39:

  1. Pneumonia fungal
  2. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  3. Rash
  4. Abdominal pain upper
  5. Breast cancer metastatic
  6. Dry mouth
  7. Fatigue (feeling of tiredness)
  8. Headache (pain in head)
  9. Libido decreased (loss of interest in sex)
  10. Malignant neoplasm progression (cancer tumour came back)

40-49:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Cardiogenic shock (inadequate circulation of blood)
  5. Cellulitis (infection under the skin)
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Gas gangrene (bacterial infection that produces gas within tissues)
  8. Groin abscess (pus in groin)
  9. Groin pain
  10. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)

50-59:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Cellulitis (infection under the skin)
  3. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  4. Abscess limb (limb infection)
  5. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  6. Genital abscess (build up of pus in genital)
  7. Perineal abscess
  8. Septic shock (shock due to blood infection)
  9. Sudden death
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Device failure
  3. Sepsis (a severe blood infection that can lead to organ failure and death)
  4. Systemic mycosis (fungal infections of the body)
  5. Trichosporon infection (a fungal infection by trichophyton)
  6. Abdominal pain
  7. Muscular weakness (muscle weakness)
  8. Cardiac failure
  9. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  10. Adenovirus infection

What are the existing conditions these people have? *

  1. High Blood Pressure: 10 people, 17.54%
  2. Nausea (feeling of having an urge to vomit): 8 people, 14.04%
  3. Constipation: 8 people, 14.04%
  4. Febrile Neutropenia (fever with reduced white blood cells): 8 people, 14.04%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 14.04%
  6. Pain: 8 people, 14.04%
  7. Weight Decreased: 7 people, 12.28%
  8. Hypotension (abnormally low blood pressure): 7 people, 12.28%
  9. Infection: 7 people, 12.28%
  10. Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Maxipime and Vancomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Maxipime and Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Maxipime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxipime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefepime hydrochloride and vancomycin (the active ingredients of Maxipime and Vancomycin, respectively), and Maxipime and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: